eicosapentaenoic acid ethyl ester and Vasospasm, Intracranial studies

Vasospasm, Intracranial: Constriction of arteries in the SKULL due to sudden, sharp, and often persistent smooth muscle contraction in blood vessels. Intracranial vasospasm results in reduced vessel lumen caliber, restricted blood flow to the brain, and BRAIN ISCHEMIA that may lead to hypoxic-ischemic brain injury (HYPOXIA-ISCHEMIA, BRAIN).

Research Excerpts

Excerpt	Relevance	Reference
"Cerebral vasospasm following subarachnoid hemorrhage (SAH) is a significant cause of morbidity and mortality and recent studies indicate that Rho-kinase plays an important role in the occurrence of such cerebral vasospasm."	6.73	Does eicosapentaenoic acid (EPA) inhibit cerebral vasospasm in patients after aneurysmal subarachnoid hemorrhage? ( Fujisawa, H; Kato, S; Kurokawa, T; Shirao, S; Suzuki, M; Yoneda, H, 2008)
"Cerebral vasospasm following subarachnoid hemorrhage (SAH) is a significant cause of morbidity and mortality and recent studies indicate that Rho-kinase plays an important role in the occurrence of such cerebral vasospasm."	2.73	Does eicosapentaenoic acid (EPA) inhibit cerebral vasospasm in patients after aneurysmal subarachnoid hemorrhage? ( Fujisawa, H; Kato, S; Kurokawa, T; Shirao, S; Suzuki, M; Yoneda, H, 2008)

Research

Studies (1)

Authors

Trials

1 trial available for eicosapentaenoic acid ethyl ester and Vasospasm, Intracranial

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors	Studies
Yoneda, H	1
Shirao, S	1
Kurokawa, T	1
Fujisawa, H	1
Kato, S	1
Suzuki, M	1